Ethical Drug Development for Rare Childhood Diseases: When There Are Limited But Promising Data in Adults, How to Choose Between Safety or Efficacy Studies?

, &
American Journal of Bioethics 20 (4):111-113 (2020)
  Copy   BIBTEX

Abstract

Volume 20, Issue 4, May 2020, Page 111-113.

Categories

Keywords

Reprint years

DOI

10.1080/15265161.2020.1730490

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 93,774

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Flexibility Required: Balancing the Interests of Children and Risk in Drug Development for Rare Pediatric Conditions.Kathryn M. Porter, Anne Stevens & Benjamin S. Wilfond - 2020 - American Journal of Bioethics 20 (4):116-118.
Bringing Known Drugs to Pediatric Research: Safety, Efficacy, and the Ambiguous Minor Increase in Minimal Risk.Akshay Sharma & Liza-Marie Johnson - 2020 - American Journal of Bioethics 20 (4):106-108.
Mind the Gap: How Should We Translate Specific Ethical Norms Into Interventions?Niels Nijsingh, Bianca Jansky, Georg Marckmann & Katja Kuehlmeyer - 2020 - American Journal of Bioethics 20 (4):89-91.
When Higher Risk Does Not Equal Greater Harm: Doing the Most Good in a Limited Pediatric Study Population.Jeff Matsler & Jamila M. Young - 2020 - American Journal of Bioethics 20 (4):118-120.
Responsible Innovation For and From Ethical Integration.John Noel Viaña, Sujatha Raman & Joan Leach - 2020 - American Journal of Bioethics 20 (4):94-97.
Ethical Training Can Turn an “Ought” to a “Can”.Ira Bedzow & Matthew Wynia - 2020 - American Journal of Bioethics 20 (4):73-75.
A Care Ethics Approach to Ethical Advocacy for Community Conditions.Philip G. Day, Kristian E. Sanchack & Robert P. Lennon - 2020 - American Journal of Bioethics 20 (4):35-37.
Greater Than Minimal Risk, No Direct Benefit – Bridging Drug Trials and Novel Therapy in Pediatric Populations.Benjamin S. Wilfond, Devan M. Duenas & Liza-Marie Johnson - 2020 - American Journal of Bioethics 20 (4):102-103.
Ethical Vaccine Recommendations in the Context of Tenuous Data: Honesty is the Best Policy.Ross McKinney - 2023 - American Journal of Bioethics 23 (10):128-130.
Clearing Muddy Waters: The Need to Reconceptualize Minor Increase over Minimal Risk in Pediatric Rare Disease Research.Devan M. Duenas, Benjamin S. Wilfond & Liza-Marie Johnson - 2020 - American Journal of Bioethics 20 (4):8-10.

Analytics

Added to PP
2020-03-25

Downloads
21 (#173,985)

6 months
12 (#1,086,452)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Citations of this work

Add more citations

References found in this work

No references found.

Add more references